Related Experiment Video

Updated: May 13, 2026

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

icb-1 Gene counteracts growth of ovarian cancer cell lines

Oliver Treeck1, Susanne Schüler, Julia Häring

  • 1Department of Obstetrics and Gynecology, University Medical Center Regensburg, Regensburg, Germany. otreeck@caritasstjosef.de

Cancer Letters
|March 12, 2013
PubMed

Insights

The icb-1 gene inhibits ovarian cancer progression. Loss of icb-1 accelerates cancer cell proliferation and upregulates key biomarkers, suggesting icb-1 is a potential therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Expression Profiling

Background:

  • The human gene icb-1 was initially identified for its role in cancer cell differentiation.
  • Understanding the specific functions of icb-1 in ovarian cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of icb-1 in ovarian cancer progression.
  • To determine the effect of icb-1 gene knockdown on ovarian cancer cell behavior and gene expression.

Main Methods:

  • Knockdown of icb-1 expression in three distinct ovarian cancer cell lines (SK-OV-3, OVCAR-3, OAW-42).
  • Microarray-based gene expression profiling to analyze global gene changes.
  • Gene network modeling to identify regulated pathways.

Main Results:

  • Loss of icb-1 expression significantly accelerated the proliferation of ovarian cancer cells.
  • Upregulation of known ovarian cancer biomarkers, including KLK10 and CLDN16, was observed.
  • Enriched gene networks indicated involvement of oncogenic pathways regulated by Estrogen Receptor alpha (ERα) and Tumor Necrosis Factor (TNF).

Conclusions:

  • The icb-1 gene functions as a suppressor of ovarian cancer cell growth and progression.
  • icb-1 may serve as a potential therapeutic target for inhibiting ovarian cancer development.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.